Determinants of unequal HIV care access among people living with HIV in Peru

Globalization and Health

Carlos F Caceres¹  Margarita Petrera¹  Maziel Girón¹  Clara Sandoval¹  Eddy R Segura¹  Alfonso Silva-Santisteban¹ 

[1] Unit of Health, Sexuality and Human Development, Cayetano Heredia University School of Public Health, Lima, Peru. Av. Armendariz 445, Lima 18, Peru

关键词: Peru;    Social determinants of health;    Transgender;    Antiretroviral treatment;    HIV;    Equity;    Health care access;   

Others  :  819309
DOI  :  10.1186/1744-8603-9-22

 received in 2012-09-11, accepted in 2013-05-10,  发布年份 2013

【 摘 要 】

Background

Equity in access to health care among people living with HIV (PLHA) has not been extensively studied in Peru despite the fact there is significant social diversity within this group. We aimed to assess the extent to which health care provision to PLHA, including ARVT, was equitable and, if appropriate, identify factors associated with lower access.

Methods

We conducted a survey among adult PLHA in four cities in Peru, recruited through respondent-driven sampling (RDS), to collect information on socio-demographic characteristics, social network size, household welfare, economic activity, use of HIV-related services including ARV treatment, and health-related out-of-pocket expenses.

Results

Between September 2008 and January 2009, 863 individuals from PLHA organizations in four cities of Peru were enrolled. Median age was 35 (IQR = 29–41), and mostly male (62%). Overall, 25% reported to be gay, 11% bisexual and 3% transgender. Most PLHA (96%) reported access to some kind of HIV-related health service, and 84% were receiving those services at a public facility. Approximately 85% of those reporting access to care were receiving antiretroviral treatment (ARV), and 17% of those not in treatment already had indication to start treatment. Among those currently on ARV, 36% percent reported out-of-pocket expenses within the last month. Transgender identity and age younger than 35 years old, were associated with lower access to health care.

Conclusions

Our findings contribute to a better social and demographic characterization of the situation of PLHAs, their access to HIV care and their source of care, and provide an assessment of equity in access. In the long term, it is expected that HIV care access, as well as its social determinants, will impact on the morbidity and mortality rates among those affected by the HIV/AIDS epidemic. HIV care providers and program managers should further characterize the barriers to healthcare access and develop strategies to resolve them by means of policy change, for the benefit of the health service users and as part of the national response to the HIV/AIDS epidemic within a human rights framework.

【 授权许可】

   
2013 Silva-Santisteban et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Commission on Social Determinants of Health (CSDH): Closing the gap in a generation: health equity through action on the social determinants of health. Geneva: WHO; 2008. [Final report of the Commission on Social Determinants of Health]
• [2]WHO: Monitoring Equity in Access to AIDS treatment programmes: a review of concepts, models, methods and indicators. Geneva: WHO; 2010. [Commissioned by the World Health Organization (Department of Ethics, Equity, Trade and Human Rights - Social Determinants of Health) and the Regional Network for Equity in Health in East and Southern Africa (EQUINET) through REACH Trust and Training and Research Support Centre (TARSC)]
• [3]Steele CB, Meléndez-Morales L, Campoluci R, DeLuca N, Dean HD: Health disparities in HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States: issues, burden, and response. Atlanta: Centers for Disease Control and Prevention (US); 2007. [A retrospective review, 2000–2004]
• [4]Blas E, SivasankaraKurup A (Eds): Equity, social determinants and public health programmes. WHO: Geneva; 2010.
• [5]Beltran VM, Harrison KM, Hall HI, Dean HD: Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB. PublicHealth Rep 2011, 126(Suppl 3):41-53.
• [6]Arrivillaga M: Social determinants and adherence to treatment among Colombian women living with HIV/AIDS. Int J EquityHealth 2012, 11(Suppl 1):A1.
• [7]United Nations General Assembly: Declaration of Commitment on HIV/AIDS. United Nations General Assembly Session on HIV/AIDS 25-25 June 2001. 2001. http://data.unaids.org/publications/irc-pub03/aidsdeclaration_en.pdf webcite
• [8]United Nations General Assembly: Progress made in the implementation of the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS. UNGASS: Report of the Secretary-General; 2010.
• [9]Caceres CF, Mendoza W: The national response to the HIV/AIDS epidemic in Peru: accomplishments and gaps–a review. J Acquir Immune Defic Syndr 2009, 51(Suppl 1):S60-S66.
• [10]Ministerio de Salud: Analisis de la situación epidemiologica del VIH/SIDA en el Perú. Lima, Perú: Direccion General de Epidemiologia-Ministerio de Salud del Perú; 2006.
• [11]Peruvian Ministry of Health: Peruvian National report about the developed progress on the implemention of the UNGASS (January 2008- December 2009). Lima, Peru: MINSA; 2010.
• [12]Caceres CF, Giron JM, Sandoval C, Lopez R, et al.: Implementation effects of GFATM-supported HIV/AIDS projects on the health sector, civil society and affected communities in Peru 2004-2007. Glob Public Health 2010, 5(3):247-265.
• [13]Perú-Universidad Peruana Cayetano Heredia CARE: Estudio de medición de línea de base de los objetivos 1-4 del componente VIH del Programa: Cerrando brechas hacia el logro de los objetivos del milenio en TBC y VIH/SIDA en el Perú. Propuesta con enfoque de descentralización multisectorial participativa (Informe Final). Lima, Peru: CARE-Perú/UPCH; 2007.
• [14]Perú-Universidad Peruana Cayetano Heredia CARE: Estudio de tercera medición de los indicadores de los Objetivos 2-4 del Componente VIH del Programa Fortalecimiento del Control del SIDA y la Tuberculosis en el Perú (Informe Final). Lima, Perú: CARE-Perú/UPCH; 2007.
• [15]Perú-Universidad Peruana Cayetano Heredia CARE: Estudio final de evaluación del componente VIH del Programa Fortalecimiento del Control del SIDA y la Tuberculosis en el Perú (Informe Final). Lima, Perú: CARE-Perú/UPCH; 2009.
• [16]Perú-Universidad Peruana Cayetano Heredia CARE: Informe de Medición de indicadores y evaluación final. Programa en VIH de V Ronda(Informe final). Lima, Perú: CARE-Perú/UPCH; 2012.
• [17]Malekinejad M, Johnston LG, Kendall C, et al.: Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav 2008, 12(Suppl 1):S105-S130.
• [18]Bravo P, Edwards A, Rollnick S, Elwyn G: Tough decisions faced by people living with HIV: a literature review of psychosocial problems. AIDS Rev 2010, 12(2):76-88.
• [19]Heckathorn DD: Respondent-driven dampling: a new approach to the study of hidden populations. Soc Probl 1997, 44(2):174-199.
• [20]Salganik MJ: Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J UrbanHealth. 2006, 83(Suppl 1):i98-i112.
• [21]Ministerio de Economia y Finazas: Propuesta metodologica para identificar a los potenciales beneficiarios de los programas sociales en el Peru. Lima, Perú: Ministerio de Economía y Finanzas; 2009.
• [22]Giron JM, Segura ER, Salazar V, et al.: Percepciones de las personas viviendo con VIH/SIDA sobre los servicios de salud y el tratamiento antiretroviral de gran actividad: Un estudio transversal en cinco ciudades del Peru. Rev Peru Med Exp SaludPublica 2007, 24(3):211-217. Retrieved from http://www.scielo.org.pe/pdf/rins/v224n213/a203v224n213.pdf webcite
• [23]Goel S, Salganik MJ: Respondent-driven sampling as Markov chain Monte Carlo. Stat Med 2009, 28(17):2202-2229.
• [24]Volz E, Heckathorn DD: Probability based estimation theory for respondent-driven sampling. J Off Stat 2008, 24(1):79-97. Retrieved from
• [25]Salganik MJ, Heckathorn DD: Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol 2004, 34(1):193-239.
• [26]Silva-Santisteban A, Salazar X, Villayzan J, Caceres CF: Understanding the HIV/AIDS epidemic in the male to female transgender population of lima, Peru: results from a sero-epidemiologic study using respondent-driven sampling. AIDS Behav 2012, 16(4):872-881.
• [27]Salazar X, Villayzán J, Silva Santisteban A, Cáceres CF: Las personas trans y la epidemia del VIH/sida en el Perú: aspectos sociales y epidemiológicos. Lima: IESSDEH, UPCH, ONUSIDA, amFAR; 2010.
• [28]Solar O, Irwin A: A conceptual framework for action on the social determinants of health. Geneva: World Health Organization; 2010. [Social Determinants of Health Discussion Paper Series 2] Monitoring Equity in Access to AIDS treatment programmes: A review of concepts, models, methods and indicators. World Health Organization
• [29]Echevarria J, Lopez de Castilla D, Seas C, Verdonck K, Gotuzzo E: Scaling-up highly active antiretroviral therapy (HAART) in Peru: problems on the horizon. J Acquir Immune Defic Syndr 2006, 43(5):625-626.
• [30]Ministerio de Salud: Informe Nacional sobre los progresos realizados en VIH en el país – Período 2010-2011 (UNGASS). Lima; 2012.
• [31]Ministerio de Salud: Norma Técnica de Salud sobre Atención Integral a Personas con VIH N° 097-MINSA/DGSP-V.01. Lima, Peru: MINSA; 2012.
• [32]Ministerio de Salud: Análisis de la mortalidad por causas especificas: VIH/SIDA, tuberculosis, causas maternas y Accidentes de transito. 2007-2008. Lima, Peru: MINSA; 2011.
• [33]Ministerio de Salud-Universidad Peruana Cayetano Heredia: Recommendations on the implementation of an HIV/AIDS antiretroviral therapy program in Peru. Lima, Peru: MINSA/UPCH; 2004.
• [34]Cunningham WE, et al.: The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Medical Care. 1999, 37(12):1270-1281.
• [35]Lonnroth , et al.: Tuberculosis: the role of risk factors and social determinants. In: Blas E and SivasankaraKurup A, eds. Equity, social determinants and public health programmes. Geneva: WHO; 2010.
• [36]Instituto Nacional de Estadistica e Informatica: Determinantes del acceso a los servicios de salud en el Peru. Lima, Peru: INEI [Online]; 2000. Available: http://www.inei.gob.pe/biblioineipub/bancopub/Est/Lib0387/PRESENTA.htm webcite [Accesed: September 20th 2009]
• [37]Joy R, Druyts EF, Brandson EK, Lima VD, et al.: Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr 2008, 47(4):500-505.